TIANA AKINS: Open Payments
NPI 1295340826 · DRESDEN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 35 payments from 11 companies in 2025. Trend: 2023 $125 · 2024 $867 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $236 |
| Otsuka America Pharmaceutical, Inc. | 5 | $99 |
| Janssen Pharmaceuticals, Inc | 3 | $79 |
| Lundbeck LLC | 3 | $72 |
| Vanda Pharmaceuticals Inc. | 2 | $71 |
| Alkermes, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: VRAYLAR, REXULTI, INVEGA SUSTENNA, HETLIOZ, ABILIFY ASIMTUFII, ARISTADA, CAPLYTA, TRINTELLIX.
Industry payments across TN — which companies pay providers there.
